BioSpace News Archive

BioCapital

Reston Hospital Center and StoneSprings Hospital Center Recognized For Excellence in Cardiac Care by Healthgrades

Reston Hospital Center and StoneSprings Hospital Center proudly announce that they have been given Five-Star ratings for the Treatment of Heart Failure and Treatment of Heart Attack by Healthgrades for 2019.

July 24, 2019
·
1 min read
Biotech Bay

Freenome Secures $160 Million to Advance Cancer Detection Blood Test

Following additional study, Freenome said it plans to seek regulatory approval under the Parallel Review Program, the first application of its platform in colorectal cancer screening.

July 24, 2019
·
3 min read
·
Alex Keown
Business

Mind the talent gap: new biologics facility to upskill future workforce

The opening of a new $11.5m biotech production and training facility at the University of Technology Sydney has been welcomed by government and industry leaders who say fostering and keeping local talent in the burgeoning Life Sciences sector is key to building a globally competitive industry.

July 24, 2019
·
4 min read
Business

Lonza on Track to Deliver Full-Year 2019 Results, Driven by Pharma Biotech Business

Double-digit sales growth delivered by Pharma Biotech & Nutrition (LPBN) segment

July 24, 2019
·
16 min read
Business

Horizon Discovery Group plc: Trading Update

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation technologies, provides a trading update for the six month period ended 30 June 2019.

July 24, 2019
·
3 min read
Business

BioCity and Oxford AHSN Partner to Accelerate Life Science Businesses in the Golden Triangle

BioCity, a pioneering life science incubator and business collective, has announced a new strategic partnership with Oxford AHSN.

July 24, 2019
·
4 min read
FDA

Pfizer’s Rituxan Biosimilar Gets Thumbs-Up from FDA for Multiple Indications

It is approved for adults with non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, granulomatosis with polyangiitis and microscopic polyangiitis.

July 24, 2019
·
3 min read
·
Mark Terry
FDA

FDA Approves Samsung Bioepis’ Humira Biosimilar

Despite the approval, Samsung Bioepis’ Hadlima will not be available in the U.S. until 2023, due to licensing deals with AbbVie, the maker of Humira.

July 24, 2019
·
2 min read
·
Alex Keown
Policy

Court Order Will Force FDA to Reconsider Braeburn’s Opioid Abuse Treatment

Braeburn has been fighting the FDA over its award of Orphan Drug Designation to another opioid use disorder treatment that will prevent competition through November 2020. More than 2 million people in the U.S. have been diagnosed with the disease.

July 24, 2019
·
3 min read
·
Alex Keown
Business

ICON Reports Second Quarter 2019 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2019.

July 24, 2019
·
8 min read